Why this strategist says ‘stay away’
UnitedHealth (UNH) stock is surging after its CEO bought $25 million in stock, even as the company faces legal and leadership challenges.
Mizuho Americas healthcare equity strategist Jared Holz joins Market Domination with Josh Lipton and Julie Hyman to explain why he’s telling clients to stay away from the stock for now.
To watch more expert insights and analysis on the latest market action, check out more Market Domination here.
